Form D · Pharmaceuticals
IDUN PHARMACEUTICALS INC
San Diego, CA · CIK 0001076413
Offering snapshot reported Jul 13, 2015 · SEC filing
- Reported sold
- $1.13M Offering amount: $1.5M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jul 8, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2015 | Initial | $1,125,000 | No comparison | 30 | SEC filing |
| Feb 4, 2015 | Amendment | $2,000,044 | $1,725,038vs Feb 25, 2014 | 30 | SEC filing |
| Oct 9, 2014 | Amendment | $500,011 | $225,005vs Feb 25, 2014 | 30 | SEC filing |
| Feb 25, 2014 | Initial | $275,006 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-243499
Source: Form D, filed Jul 13, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Gerber, M.D. | Director |
| David F. Hale | Director, Executive |
| Paul Klingenstein | Director |
| Louis Lacasse | Director |
| Shahzad Malik | Director |
| Steven J. Mento, Ph.D. | Director |
| Marc O. Perret | Director |
| James Scopa | Director |
| Harold Van Wart, Ph.D. | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
12463 Rancho Bernardo Rd., #554
San Diego, CA, 92128
San Diego, CA, 92128